{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:52:57Z","timestamp":1790898777282,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Xenobiotic and folate metabolic pathways are important for the maintenance of genetic stability and may influence susceptibility to the development of childhood acute lymphoblastic leukaemia (ALL). In this study, we investigated 10 polymorphisms in 6 genes (<jats:italic>GSTM1<\/jats:italic>\u2010present\/null, <jats:italic>GSTT1<\/jats:italic>\u2010present\/null, <jats:italic>GSTP1<\/jats:italic> 1578A\u2009&gt;\u2009G, <jats:italic>NQO1<\/jats:italic> 609C\u2009&gt;\u2009T, <jats:italic>MTHFR<\/jats:italic> 677C\u2009&gt;\u2009T, <jats:italic>MTHFR<\/jats:italic> 1298A\u2009&gt;\u2009C, <jats:italic>MTHFD1<\/jats:italic> 1958G\u2009&gt;\u2009A, 3\u2032\u2010<jats:italic>TYMS<\/jats:italic> 1494 6bp\u2010deletion\/insertion, 5\u2032\u2010<jats:italic>TYMS<\/jats:italic> 28bp\u2010tandem repeats, and <jats:italic>SLC19A1<\/jats:italic> 80G\u2009&gt;\u2009A) in a cohort of 185 Javanese children with ALL and 177 healthy controls. In ALL patients, none of the polymorphisms demonstrated a statistically significant association with ALL after correcting for multiple comparisons. Gender\u2010stratified analysis showed that in girls, <jats:italic>GSTT1<\/jats:italic>\u2010null genotype was associated with increased ALL risk (OR\u2009=\u20092.20; <jats:italic>p<\/jats:italic>\u2009=\u20090.027), while <jats:italic>GSTP1<\/jats:italic> 1578AG genotype was associated with reduced risk (OR\u2009=\u20090.43; <jats:italic>p<\/jats:italic>\u2009=\u20090.031). Strong linkage disequilibrium between the MTHFR 677C\u2009&gt;\u2009T and 1298A\u2009&gt;\u2009C polymorphisms was observed (<jats:italic>D<\/jats:italic>\u2032\u2009=\u20091.0; <jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.072). The haplotypes 677C\u20101298C and 677T\u20101298A were associated with a reduced risk of ALL (OR\u2009=\u20090.68 and 0.64, respectively; gender\u2010adjusted global <jats:italic>p<\/jats:italic>\u2009=\u20090.028). Classification and regression tree (CART) analysis was employed to identify potential high\u2010order gene\u2010gene interactions and cluster subjects into susceptibility groups. <jats:italic>SLC19A1<\/jats:italic> 80G\u2009&gt;\u2009A emerged as the predominant polymorphism associated with risk of ALL. Individuals simultaneously carrying <jats:italic>MTHFR<\/jats:italic> 1298AA, 3'\u2010<jats:italic>TYMS<\/jats:italic> 6bp deletion(s) and <jats:italic>SLC19A1<\/jats:italic> 80A\u2010allele(s) were at higher disease risk (OR\u2009=\u20092.21; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). On the contrary, simultaneous possession of <jats:italic>MTHFR<\/jats:italic> 1298CC, 3'\u2010<jats:italic>TYMS<\/jats:italic> 6bp homozygosity and <jats:italic>SLC19A1<\/jats:italic> 80A\u2010allele(s) conferred lower risk (OR\u2009=\u20090.25; <jats:italic>p<\/jats:italic>\u2009=\u20090.004). Carriage of <jats:italic>NQO1<\/jats:italic> 609C\u2010allele amongst <jats:italic>SLC19A1<\/jats:italic> 80GG genotype was associated with lower risk (OR\u2009=\u20090.47; <jats:italic>p<\/jats:italic>\u2009=\u20090.003). In conclusion, our study has demonstrated the importance of gender and gene\u2010gene interaction within the xenobiotic and folate pathways in modulating childhood ALL susceptibility. Copyright \u00a9 2010 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hon.965","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T01:07:00Z","timestamp":1283908020000},"page":"116-123","source":"Crossref","is-referenced-by-count":44,"title":["Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children"],"prefix":"10.1002","volume":"29","author":[{"given":"Jason Yong\u2010Sheng","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewa G","family":"Ugrasena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny Wai\u2010Kiong","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen Eng\u2010Juh","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1515\/REVEH.2001.16.4.263"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.11.2309"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00206-8"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(99)00213-X"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404474"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.01.014"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-165928"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.07.003"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03750.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3786"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1794"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403613"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1515\/bchm3.1994.375.7.439"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-111"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01254.x"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20018"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199604000-00005"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.14.1159"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3000271"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.54.8.693"},{"key":"e_1_2_8_22_2","first-page":"1","volume-title":"Resampling\u2010Based Multiple Testing","author":"Westfall PH","year":"1993"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btl268"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.04.007"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.11.1949"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2000.570405.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.10.006"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10752"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1134\/S0026893308020039"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfm233"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X112480"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207358"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05690"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0808700"},{"key":"e_1_2_8_35_2","first-page":"571","article-title":"Risk stratification for LDL cholesterol using induction technique","volume":"129","author":"Ho SH","year":"2007","journal-title":"Stud Health Technol Inform"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2009.00511.x"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.05.009"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/132.8.2413S"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.1998.2714"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/301825"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(02)00081-9"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-004-1243-2"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.965","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T19:34:28Z","timestamp":1700595268000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1002\/hon.965"],"URL":"https:\/\/doi.org\/10.1002\/hon.965","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]}}}